$416.54
0.580.14%
At close: Nov 13, 4:00 PM EST
$416.54
N/A
After Hours: Nov 13, 6:44 PM EST

The average analyst price target for BeOne Medicines is $399.95, 4.0% below the current price. Of 16 analysts, 16 rate it Buy. Targets range from $311 to $476. The latest change came on Nov 13, 2026, when Morgan Stanley raised its price target on BeOne Medicines from $465 to $476 and kept an Overweight rating.
Price Target Range — 8 Quarters
Analyst Consensus — 16 Analysts
Rating Trend — Last 9 Months